Macitentan, sold under the brand name Opsumit, is an endothelin receptor antagonist developed by Actelion and approved for the treatment of pulmonary arterial...
11 KB (1,012 words) - 16:29, 7 September 2024
Macitentan/tadalafil, sold under the brand name Opsynvi, is a fixed dose combination medication used for the treatment of pulmonary arterial hypertension...
7 KB (382 words) - 07:26, 2 October 2024
both endothelin A (ETA) and B receptors (ETB) aprocitentan, bosentan, macitentan, tezosentan Selective ETA Receptor Antagonists, which affect endothelin...
1 KB (108 words) - 13:59, 11 July 2024
include epoprostenol, treprostinil, iloprost, bosentan, ambrisentan, macitentan, and sildenafil, tadalafil, selexipag, riociguat. Lung transplantation...
89 KB (8,858 words) - 17:12, 8 November 2024
Ambrisentan C02KX03 Sitaxentan C02KX04 Macitentan C02KX05 Riociguat C02KX52 Ambrisentan and tadalafil C02KX54 Macitentan and tadalafil C02LA01 Reserpine and...
5 KB (417 words) - 23:25, 25 March 2024
doi:10.1177/1756287214531639. PMC 4054509. PMID 25083163. "Ppsynvi (macitentan and tadalafil) Becomes the First and Only Health Canada-Approved Once...
35 KB (3,243 words) - 04:46, 27 October 2024
in Pennsylvania found that a potential side effect of medications like macitentan, an endothelin receptor antagonist that is used to treat pulmonary arterial...
20 KB (2,616 words) - 16:45, 29 April 2024
Mp–My M-Predrol M-Zole M.V.C. 9+3 M.V.I. mabuprofen (INN) mabuterol (INN) macitentan (INN) Macrobid Macrodantin macrosalb (131 I) (INN) macrosalb (99m tc)...
4 KB (269 words) - 05:30, 21 September 2024
for the PAH (Pulmonary Arterial Hypertension) market include: Opsumit (Macitentan): Actelion received approval from the FDA for the manufacture of this...
25 KB (2,584 words) - 21:16, 20 October 2024
potentially lethal effects in the liver. Bosentan was a precursor to macitentan, which was approved in 2013. Davenport AP, Hyndman KA, Dhaun N, Southan...
17 KB (1,655 words) - 20:05, 8 December 2023
Other drug trials are ongoing in patients with inoperable CTEPH, with macitentan recently proving efficacy and safety in MERIT Pulmonary endarterectomy...
27 KB (2,880 words) - 21:59, 23 June 2024
BQ-788 Clazosentan Darusentan Edonentan Enrasentan Fandosentan Feloprentan Macitentan Nebentan Sitaxentan Sparsentan Tezosentan Zibotentan Agonists Galanin...
13 KB (706 words) - 20:05, 20 August 2024
BQ-788 Clazosentan Darusentan Edonentan Enrasentan Fandosentan Feloprentan Macitentan Nebentan Sitaxentan Sparsentan Tezosentan Zibotentan Agonists: Galanin...
14 KB (825 words) - 19:41, 19 August 2024